Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumours. gemcitabine-based regimens have been used as front-line treatments for patients with advanced pancreatic cancer. gemcitabine may initially show a response, but most often multi-drug resistance (MDR) rapidly develops...
Main Author: | Bugde, Piyush (Author) |
---|---|
Other Authors: | Li, Yan (Contributor), Lu, Jun (Contributor), Merien, Fabrice (Contributor) |
Format: | Others |
Published: |
Auckland University of Technology,
2019-07-16T23:09:08Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Reversing ABCC2-Mediated Oxaliplatin Resistance in Human PANC-1 Cells Using the CRISPR_cas9 System
by: Cullen, Camren
Published: (2021) -
CRISPR/Cas9-Mediated Three Nucleotide Insertion Corrects a Deletion Mutation in MRP1/ABCC1 and Restores Its Proper Folding and Function
by: Qinqin Xu, et al.
Published: (2017-06-01) -
Genome editing of the SfABCC2 gene confers resistance to Cry1F toxin from Bacillus thuringiensis in Spodoptera frugiperda
by: Ming-hui JIN, et al.
Published: (2021-03-01) -
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients
by: Sauer Rolf, et al.
Published: (2011-07-01) -
A Human ABC Transporter ABCC4 Gene SNP (rs11568658, 559 G > T, G187W) Reduces ABCC4-Dependent Drug Resistance
by: Megumi Tsukamoto, et al.
Published: (2019-01-01)